Kevin Winthrop


  • 14455 Citations
  • 52 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Rheumatoid Arthritis Medicine & Life Sciences
Nontuberculous Mycobacteria Medicine & Life Sciences
Antirheumatic Agents Medicine & Life Sciences
Infection Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Biological Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2020

Mycobacterium avium Complex
Lung Diseases
Orphan Drug Production
Herpes Zoster Vaccine
Chickenpox Vaccine
Herpes Zoster
Rheumatoid Arthritis
Biological Therapy
Tumor Necrosis Factor-alpha
Immunosuppressive Agents

Research Output 1997 2019

Advancing translational science for pulmonary nontuberculous mycobacterial infections: A road map for research

Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E. L., Olivier, K. N., Ordway, D. J., Prevots, D. R., Sacchettini, J. C., Salfinger, M. & 4 othersSassetti, C. M., Sizemore, C. F., Winthrop, K. & Zelazny, A. M., Apr 15 2019, In : American journal of respiratory and critical care medicine. 199, 8, p. 947-951 5 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response

Skopelja-Gardner, S., Theprungsirikul, J., Meagher, R. E., Beliveau, C. M., Bradley, K. E., Avery, M., Henkle, E., Siegel, S., Gifford, A. H., Winthrop, K. & Rigby, W. F. C., Feb 1 2019, In : European Respiratory Journal. 53, 2, 1801891.

Research output: Contribution to journalLetter

Pseudomonas aeruginosa
Immunoglobulin G
bactericidal permeability increasing protein

Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: Results from a long-term extension trial substudy

Winthrop, K., Bingham, C. O., Komocsar, W. J., Bradley, J., Issa, M., Klar, R. & Kartman, C. E., Apr 18 2019, In : Arthritis Research and Therapy. 21, 1, 102.

Research output: Contribution to journalArticle

Open Access
Pneumococcal Vaccines
Tetanus Toxoid
Rheumatoid Arthritis
Human Influenza
Rheumatoid Arthritis
Randomized Controlled Trials

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials

Harigai, M., Takeuchi, T., Smolen, J. S., Winthrop, K., Nishikawa, A., Rooney, T. P., Saifan, C. G., Issa, M., Isaka, Y., Akashi, N., Ishii, T. & Tanaka, Y., Jan 1 2019, In : Modern Rheumatology.

Research output: Contribution to journalArticle

Open Access
Rheumatoid Arthritis
Herpes Zoster